The study published Monday in the Canadian Medical Association Journal (CMAJ) outlines the case of the woman who was treated at an emergency department after experiencing "progressive leg weakness and ...
“So, basically, in my opinion, this is now the standard of care for a large majority of patients with anemia [and] lower-risk MDS.” The Food and Drug Administration (FDA) approved Reblozyl in 2020 for ...